Probiotic Research in Therapeutics

14.11.2021

Englisch

Englisch

9789811582165

Springer Singapore

Nein

367

Broschiert

Volume 1: Applications in Cancers and Immunological Diseases

Dr Indu Pal Kaur is presently the Professor and Chairperson, at the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, India. She has more than 25 years of teaching and research experience to her credit. She was Director Sophisticated Analytical Instrumentation Facility, Panjab University, from 2012 to 2015 and Dean - Faculty of Pharmaceutical Sciences, for session 2017-18. Her research forte is enhancing bioperformance of drugs, plant extracts/phytochemicals and small/large biomolecules viz. siRNA and probiotics using active-tailored delivery systems. She has been granted four Indian and one US patents and has filed 22 patents in the past 10 years. She has produced 23 PhDs and 55 postgraduates. She received funding to the tune of 72.3 million INR from Government agencies and has a couple of Industrial consultancies amounting to 15.3 million INR. Her research work was funded twice (2017 and 2020) by DST and Science and Techno^ 130 high impact International publications, and her group has received 31 Best Paper awards at National and International Conferences. She is a US-Fulbright fellow (2017-18) and was awarded Women Scientist Award -2018 by Organisation of Pharmaceutical Producers of India (OPPI). She has also been graced with BRIC Technology Exposition Award, consecutively for 2019 and 2020, Tynor Innovation Award- 2019 and Researcher of the Year award 2019, by Sunpure Research Incubation Center. Emphasis of her work lies on Industrial and clinical translation and is reflected through her three technology transfers to two Indian industries.

Pharmabiotics, Microtherapeutics, Exposomes, Gut dysbiosis, Colorectal cancer

PNB - Medizinische Chemie, Pharmazeutische Chemie MJCM - Immunologie TCB - Biotechnologie

235 mm

15.5 cm